Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: An open label study

Human Psychopharmacology

Volumn 19, Issue 3, 2004, Pages 181-185

  Bahk, Won Myong ^a   Yoon, Bo Hyun ^b   Lee, Kyoung Uk ^a   Chae, Jeong Ho ^a  

^a The Catholic University of Korea   (South Korea)

^b Naju National Hospital   (South Korea)

Author keywords

Bipolar disorder; Pharmacotherapy; Quetiapine

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; CARBAMAZEPINE; LITHIUM; LORAZEPAM; QUETIAPINE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR MANIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HAMILTON SCALE; HUMAN; MALE; MEDICAL ASSESSMENT; OPEN STUDY; PARKINSONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TARDIVE DYSKINESIA;

ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES;

EID: 1942424172     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.577     Document Type: Article

References (49)

1. Alderfer BS, Allen MH. 2003. Treatment of agitation in bipolar disorder across the life cycle. J Clin Psychiatry 64(Suppl. 4): 3-9.
2. Brecher M, Huizar K, Elbaghdady A. 2003. Quetiapine monotherapy for acute mania associated with bipolar disorder (poster). In The 27th Nordic Psychiatric Congress August 13-16; Reykjavik, Iceland. NPC: Reykjavik.
3. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. 2002. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord 4: 406-411.
4. Calabrese JR, Kimmel SE, Woyshville MJ, et al. 1996. Clozapine for treatment-refractory mania. Am J Psychiatry 153: 759-764.
5. Casey DE. 1996. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 57(Suppl. 11): 40-45.
6. Chouinard G, Annable L, Ross-Chouinard A, Kropsky ML. 1979. Ethopropazine and benztropine in neuroleptic-induced parkinsonism. J Clin Psychiatry 40: 147-152.
7. Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM. 2002. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41: 1216-1223.
8. Dev V, Raniwalla J. 2000. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf 23: 295-307.
9. Dunayevich E, Strakowski SM. 2000. Quetiapine for treatment-resistant mania. Am J Psychiatry 157: 1341.
10. Esparon J, Kolloori J, Naylor GJ, McHarg AM, Smith AH, Hopwood SE. 1986. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry 148: 723-725.
11. First MB, Spitzer RL, Gibbon M, Williams JBW. 1995. Structured Clinical Interview for DSM-IV Axis I Disorders. American Psychiatric Press: New York, NY.
12. Garfinkel PE, Stancer HC, Persad E. 1980. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 2: 279-288.
13. Ghaemi SN, Goldberg JF, Ko JY, et al. 2002. Quetiapine treatment of rapid cycling bipolar disorder: an open prospective study (poster). In The 42nd Annual Meeting of the New Clinical Drug Evaulation Unit June 10-13; Boca Raton, FL. NCDEU: Boca Raton.
14. Ghaemi SN, Katzow JJ. 1999. The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 11: 137-140.
15. Ghaemi SN, Ko JY. 2001. Quetiapine-related tardive dyskinesia. Am J Psychiatry 158: 10.
16. Goldstein JM. 1999. Atypical antipsychotic drugs: beyond acute psychosis, new directions. Emerg Drugs 4: 127-151.
17. Guy W (ed.). 1976. ECDEU Assessment Manual for Psychopharmacology. Publication ADM 76-338. US Department of Health, Education, and Welfare: Washington, DC; 218-222.
18. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
19. Hermesh H, Alzenberg D, Weizman A, Lapidot M, Mayor C, Munitz H. 1992. Risk for definite neuroleptic malignant syndrome: prospective study in 223 consecutive inpatients. Br J Psychiatry 161: 254-257.
20. 2A receptor blockade by quetiapine: an R91150 single photon emission tomography study. Psychopharmacology (Berl) 157: 60-66.
21. Jones M, Huizar K. 2003. Quetiapine monotherapy for mania associated with bipolar disorder (poster). In The 156th Annual Meeting of the American Psychiatric Association May 17-22; San Francisco, California. APA: San Fransisco.
22. Kane JM. 1988. The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 49: 12-13.
23. Kane JM, Smith JM. 1982. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39: 473-481.
24. Kasper S, Muller-Spahn F. 2000. Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother 1: 783-801.
25. Keck PE, McElroy SL, Strakowski SM, Balistreri TM, Kizer DI, West SA. 1996. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 57: 147-151.
26. Lane HY, Lin YC, Chang WH. 1998. Mania induced by risperidone: dose related? J Clin Psychiatry 59: 85-86.
27. Lykouras L, Oulis P, Hatzimanolis J. 2003. Manic symptoms associated with quetiapine treatment. Eur Neuropsychopharmacol 13: 135-136.
28. Mukherjee S, Rosen AM, Caracci G, Shukla S. 1986. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 43: 342-346.
29. Mullen JA, Devine NA, Sweltzer DE. 2003. Quetiapine versus placebo as adjunct to lithium or divalproex for the treatment of bipolar mania (poster). In The 156th Annual Meeting of the American Psychiatric Association May 17-22; San Francisco, California. APA: San Fransisco.
30. Nasrallah HA, Churchill CM, Hamdan-Allan GA. 1988. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 145: 1455-1456.
31. Nemeroff CB, Kinkead B, Goldstein J. 2002. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. J Clin Psychiatry 63(Suppl. 13): 5-11.
32. Overall J, Gorham D. 1962. The Brief Psychiatric Rating Scale. Psychol Rep 10: 799-812.
33. Paulsson B, Huizar K. 2003. Quetiapine monotherapy for the treatment of bipolar mania (poster). In The Fifth International Congress on Bipolar Disorder June 12-14; Pittsburgh, Pennsylvania. ISBD: Pittsburgh.
34. Prien RF, Caffey EM, Jr, Klett CJ. 1972. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 26: 146-153.
35. Reimherr FW. 2001. Quetiapine effectively treats bipolar disorder and attention-deficit/hyperactivity disorder in adolescent patients (poster). In The American Psychiatric Association-53rd Institute on Psychiatric Services Oct 10-14; Orlando, FL. APA: Orlando.
36. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. 2002. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 159: 1146-1154.
37. Sajatovic M, Brescan DW, Perez DE, et al. 2001. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry 62: 728-732.
38. Schaller JL, Behar D. 1999. Quetiapine for refractory mania in a child. J Am Acad Child Adolesc Psychiatry 38: 498-499.
39. Segal J, Berk M, Brook S. 1998. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21: 176-180.
40. Sernyak MJ, Griffin RA, Johnson RM, Pearsall HR, Wexler BE, Woods SW. 1994. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 151: 133-135.
41. Sernyak MJ, Woods SW. 1993. Chronic neuroleptic use in manic-depressive illness. Psychopharmacol Bull 29: 375-381.
42. Tohen M, Jacobs TG, Grundy SL, et al. 2000. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 57: 841-849.
43. Tohen M, Sanger TM, McElroy SL, et al. 1999. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 156: 702-709.
44. Vieta E, Parramon G, Padrell E, et al. 2002. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 4: 335-340.
45. Yatham LN. 2000. Safety and efficacy of risperidone as combination therapy for the manic phase of bipolar disorder: preliminary findings of a randomized, double-blind study (RIS-INT-46) (poster). In The 22nd Annual Meeting of the Collegium Internationale Neuro-Psychopharmacologicum July 9-13; Brussels, Belgium. CINP: Brussels.
46. Yatham LN. 2002. The role of novel antipsychotics in bipolar disorders. J Clin Psychiatry 63(Suppl. 3): 10-14.
47. Young R, Biggs J, Meyer D. 1978. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 133: 429-435.
48. Zarate CA, Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J. 2000. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 61: 185-189.
49. Zarate CA, Jr, Tohen M. 2000. Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry 61: 33-38.